Andy Sassine, CFO of Arcturus Therapeutics Holdings Inc. ($ARCT), made two open market purchases totaling about $41,000 in the last year, with the most recent on August 15, 2025. These buys rank 3,212th among nearly 5,000 insiders, below the average purchase of $1.46 million across 3.3 transactions. Sassine reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 15, 2025 | Arcturus Therapeutics Holdings Inc. | $ARCT | SASSINE ANDY | Chief Financial Officer | P | Common Stock | 1238 | $16.56 | 221,764.0000 | 27,119,823 | 0.56% | 0.00% |
| Aug. 15, 2025 | Arcturus Therapeutics Holdings Inc. | $ARCT | SASSINE ANDY | Chief Financial Officer | P | Common Stock | 1238 | $16.56 | 221,764.0000 | 27,119,823 | 0.56% | 0.00% |
| Dec. 16, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | SASSINE ANDY | Chief Financial Officer | A | Employee Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | SASSINE ANDY | Chief Financial Officer | S | Common Stock | 50000 | $32.03 | 220,526.0000 | 0 | 18.48% | 0.00% |
| Dec. 15, 2023 | Arcturus Therapeutics Holdings Inc. | $ARCT | SASSINE ANDY | Chief Financial Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2023 | Arcturus Therapeutics Holdings Inc. | $ARCT | SASSINE ANDY | Chief Financial Officer | A | Common Stock | 1223 | $17.37 | 270,526.0000 | 0 | 0.45% | 0.00% |